|
|
|
|
 |
|
|
|
Publications : 2011
|
|
1: |
A multilocus technique for risk evaluation of patients with neuroblastoma.
|
| |
|
Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJ, Pötschger U, Ambros PF.
Clin Cancer Res. |
|
2: |
Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
|
| |
|
Coulon A, Flahaut M, Mühlethaler-Mottet A, Meier R, Liberman J, Balmas-Bourloud K, Nardou K, Yan P, Tercier S, Joseph JM, Sommer L, Gross N.
Neoplasia |
|
3: |
Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.
|
| |
|
Mühlethaler-Mottet A, Flahaut M, Bourloud KB, Nardou K, Coulon A, Liberman J, Thome M, Gross N.
Cell Death Dis. |
|
4: |
The CXCR7/CXCR4/CXCL12 axis involvement in the control of growth and differentiation in human neuroblastoma (submitted in Journal of Pathology) |
| |
|
J. Liberman, H. Sartelet, M. Flahaut, A. Mühlethaler-Mottet, A. Coulon, C. Nyalendo, G. Vassal, J. M. Joseph and N. Gross.
The Journal of Pathology |
Publications : 2009
|
|
1: |
Chemokines in neuroectodermal cancers: the crucial growth signal from the soil.
|
| |
|
Gross N, Meier R.
Semin Cancer Biol. |
|
2: |
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
|
| |
|
Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Beckmann JS, Joseph JM, Mühlethaler-Mottet A, Gross N.
Oncogene |
Publications : 2008
|
|
1: |
Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.
|
| |
|
A. Muhlethaler-Mottet, R. Meier, M. Flahaut, K. Balmas-Bourloud, K. Nardou, JM. Joseph, N. Gross.
Mol. Cancer. |
Publications : 2007
|
|
1: |
The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion.
|
| |
|
R. Meier, A. Muhlethaler-Mottet, M. Flahaut, A. Coulon, C. Fusco, F. Louache, K. Auderset, KB. Bourloud, E. Daudigeos, C. Ruegg, G. Vassal, N. Gross, JM. Joseph.
PLoS ONE |
Publications : 2006
|
|
1: |
Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
|
| |
|
A. Muhlethaler-Mottet, M. Flahaut, K. Balmas Bourloud, K. Auderset, R. Meier, JM. Joseph, N. Gross
BMC Cancer |
|
2: |
Le neuroblastome.
|
| |
|
M. Beck Popovic, JM. Joseph, N. Gross.
Rev Med Suisse |
|
3: |
Molecular Cytogenetic Characterization of Doxorubicin-Resistant Neuroblastoma Cell Lines: Evidence that Acquired Multi-Drug Resistance Results From a Unique Large Amplification of 7q21 region.
|
| |
|
M. Flahaut, A. Mühlethaler-Mottet, D. Martinet, S. Fattet, K. Balmas Bourloud, K. Auderset, R. Meier, N. Besuchet Schmutz, O. Delattre, JM. Joseph and N. Gross.
Genes Chromosomes Cancer |
|
4: |
Persistent inhibition of FLIPL expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells.
|
| |
|
M. Flahaut, A. Mühlethaler-Mottet, K. Auderset, K. Balmas Bourloud, R. Meier, JM. Joseph, M. Beck Popovic and N. Gross.
Apoptosis |
Publications : 2005
|
|
1: |
In vivo echographic evidence of tumoral vascularisation and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
|
| |
|
JM. Joseph, N. Gross, N. Lassau, V. Rouffiac, P. Opolon, L. Laudani, K. Auderset, JF. Geay, A. Mühlethaler and G. Vassal.
Int J Cancer |
|
2: |
Standardization of the Immunocytochemical Detection of Neuroblastoma Cells in Bone Marrow.
|
| |
|
K. Swerts, PF. Ambros, C. Brouzes, JM. Navarro, N. Gross, D. Rampling, R. Schumacher-Kuckelkorn, AR. Sementa, R. Ladenstein, K. Beiske.
J Histochem Cytochem |
Publications : 2004
|
|
1: |
Drug-mediated sensitization to TRAIL-induced apoptosis in capsase-8 complemented neuroblastoma cells proceeds via activations of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.
|
| |
|
A. Mühlethaler, K. Balmas, K. Auderset, JM. Joseph and N. Gross
Oncogene |
Publications : 2003
|
|
1: |
High level of stabilized angiostatin mediated by adenovirus delivery do not impair the growth of human neuroblastoma xenograft.
|
| |
|
JM. Joseph, C. Bouquet, P. Opolon, J. Morizet, G. Aubert, J. Rössler, N. Gross, M. Perricaudet, G. Vassal
Cancer Gene Ther. |
|
2: |
Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma.
|
| |
|
P. Yan, A. Mühlethaler, K. Balmas Bourloud, M. Nenadov Beck, and N. Gross.
Genes Chromosomes Cancer |
|
3: |
Quality assessment of genetic markers used for therapy stratification.
|
| |
|
IM. Ambros, J. Benard, M. Boavida, N. Bown, H. Caron, V. Combaret, J. Couturier, C. Darnfors, O. Delattre, J. Freeman-Edward, C. Gambini, N. Gross, CM. Hattinger, A. Luegmayr, J. Lunec, T. Martinsson, K. Mazzocco, S. Navarro, R. Noguera, S. O'Neill, U. Potschger, S. Rumpler, F. Speleman, GP. Tonini, A. Valent, N. Van Roy, G. Amann, B. De Bernardi, P. Kogner, R. Ladenstein, J. Michon, AD. Pearson, PF. Ambros.
J Clin Oncol. |
|
4: |
Restoration of TRAIL-induced apoptosis in a caspase-8 deficient neuroblastoma cell line by stable re-expression of caspase-8.
|
| |
|
A. Mühlethaler, K. Balmas, K. Auderset, JM. Joseph and N. Gross.
Annals of the New York Academy of Sciences |
Publications : 2002
|
|
1: |
Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
|
| |
|
S. Hopkins-Donaldson, P. Yan, K. Balmas Bourloud, A. Muhlethaler, JL. Bodmer and N. Gross.
Oncogene |
Publications : 2001
|
|
1: |
Expression of CD44 and its isoforms in the human fetal neuroblast.
|
| |
|
G. Kaya, R. Laurini, P. Chaubert and N. Gross.
Applied Immunochemistry and Molecular Morphology |
|
2: |
Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.
|
| |
|
N. Gross, K. Balmas, C. Beretta Brognara, J. Tschopp.
J. Med. Ped. Oncol |
|
3: |
Pathology and Biology Guidelines for respectable and unresectable neuroblastic tumors and bone marrow examination guidelines.
|
| |
|
P. Ambros, I. Ambros, N. Gross, et al.
Med Ped Oncol |
|
4: |
Role of CD44H carbohydrate structure in neuroblastoma adhesive properties.
|
| |
|
N. Gross, K. Balmas, C. Beretta Brognara.
Med. Ped. Oncol, |
Publications : 2000
|
|
1: |
Adhesion molecules in neuroblastoma. |
| |
|
M. Favrot and N. Gross.
Chapter in a volume dedicated to biological and clinical aspects of neuroblastoma, entitled « Neuroblastoma », editors P.A Voûte, T. Sawada and N. Tsuchida, Elsevier Science, B.V., Amsterdam |
|
2: |
Loss of caspase 8 expression is related to malignancy and resistance to TRAIL-induced apoptosis.
|
| |
|
S. Hopkins Donaldson, JL. Bodmer, K. Balmas Bourloud, C. Beretta Brognara, J. Tschopp and N. Gross.
Med. Ped. Oncol. |
|
3: |
Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to TRAIL-induced apoptosis.
|
| |
|
S. Hopkins Donaldson, JL. Bodmer, K. Balmas Bourloud, C. Beretta Brognara, J. Tschopp, and N. Gross.
Cancer Res. |
|
4: |
NMYC-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells.
|
| |
|
N. Gross, K. Balmas Bourloud, C. Beretta Brognara.
Exp. Cell Res. |
|
|
|
